The present invention provides methods of diagnosis of Alzheimers disease including assessing the levels of certain microRNAs in a subject and comparing these to levels in subjects not exhibiting the disease. The identified measurements provide input for improved diagnoses of Alzheimers disease as compared to certain other forms of dementias, which allows more effective treatment regimens.
